Antony Rosen

Active 1989–2025

91
Papers
18,073
Citations
73
h-index
89
i10-index

Citations

Citations per year for Antony Rosen1979: 1 citations1989: 1 citations1990: 3 citations1991: 13 citations1992: 26 citations1993: 21 citations1994: 17 citations1995: 59 citations1996: 105 citations1997: 171 citations1998: 209 citations1999: 221 citations2000: 263 citations2001: 188 citations2002: 212 citations2003: 193 citations2004: 171 citations2005: 187 citations2006: 172 citations2007: 146 citations2008: 140 citations2009: 142 citations2010: 146 citations2011: 152 citations2012: 115 citations2013: 125 citations2014: 131 citations2015: 143 citations2016: 132 citations2017: 160 citations2018: 144 citations2019: 443 citations2020: 425 citations2021: 403 citations2022: 390 citations2023: 196 citations2024: 379 citations2025: 140 citations2026: 6 citations1980–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,384 citing papers, 35.2% of this breakdownUnited Kingdom: 508 citing papers, 7.5% of this breakdownChina: 378 citing papers, 5.6% of this breakdownGermany: 370 citing papers, 5.5% of this breakdownFrance: 352 citing papers, 5.2% of this breakdownItaly: 302 citing papers, 4.5% of this breakdownCanada: 300 citing papers, 4.4% of this breakdownJapan: 262 citing papers, 3.9% of this breakdownAustralia: 191 citing papers, 2.8% of this breakdownNetherlands: 187 citing papers, 2.8% of this breakdownSweden: 173 citing papers, 2.6% of this breakdownSpain: 128 citing papers, 1.9% of this breakdown
0%35.2%Other 18.1%

Fields

  • Medicine47.1%
  • Biochemistry, Genetics and Molecular Biology31.9%
  • Immunology and Microbiology16%
  • Dentistry1.5%
  • Neuroscience0.8%
  • Agricultural and Biological Sciences0.5%
  • Other2.2%

Topics

  • Inflammatory Myopathies and Dermatomyositis4.5%
  • Cell death mechanisms and regulation4.5%
  • Systemic Lupus Erythematosus Research4.1%
  • Rheumatoid Arthritis Research and Therapies2.9%
  • T-cell and B-cell Immunology2.5%
  • Systemic Sclerosis and Related Diseases2.5%
  • Other79%

Coauthors

All papers

Open in search
  1. Aggregatibacter actinomycetemcomitans –induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis

    Authors: , , , , , , , , , , , - Science Translational Medicine 2016 cited by 550

  2. The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE

    Authors: , , , , , , , , , , , , , , - JCI Insight 2023 cited by 59

  3. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

    Authors: , , , , , , - Arthritis & Rheumatism 2010 cited by 688

  4. Immune-Mediated Pore-Forming Pathways Induce Cellular Hypercitrullination and Generate Citrullinated Autoantigens in Rheumatoid Arthritis

    Authors: , , , , , , , , - Science Translational Medicine 2013 cited by 247

  5. The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps

    Authors: , , , , , , , , , , , , - eLife 2022 cited by 57

  6. Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity

    Authors: , , , , , - Science Translational Medicine 2013 cited by 165

  7. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.

    Authors: , , - The Journal of Experimental Medicine 1994 cited by 1,717

  8. Type I interferons: crucial participants in disease amplification in autoimmunity

    Authors: , - Nature Reviews Rheumatology 2010 cited by 256

  9. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Hines, William Clarke, Richard E. Rothman, Andrew Pekosz, Katherine Fenstermacher, Zitong Wang, Scott L. Zeger, Antony Rosen - JCI Insight 2022 cited by 55

  10. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

    Authors: , , , , - Journal of the American Academy of Dermatology 2011 cited by 550

  11. Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status

    Authors: , , , , - The Journal of Experimental Medicine 1999 cited by 487

  12. Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

    Authors: , , , , , , , , , , , , , , - Science 2013 cited by 434

  13. Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence

    Authors: , , , , , , - Journal of Clinical Investigation 2022 cited by 63

  14. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis

    Authors: , , , , , , , , , - Arthritis & Rheumatism 2010 cited by 140

  15. Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 107

  16. Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population

    Authors: , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2022 cited by 45

  17. Association of Anti‐CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti–Transcriptional Intermediary Factor 1γ–Positive Dermatomyositis

    Authors: , , , , , , , , , , , - Arthritis & Rheumatology 2023 cited by 33

  18. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis

    Authors: , , , - Annals of the Rheumatic Diseases 2011 cited by 172

  19. Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γ

    Authors: , , , , , , , - Arthritis & Rheumatism 2013 cited by 401

  20. Histidyl–tRNA Synthetase and Asparaginyl–tRNA Synthetase, Autoantigens in Myositis, Activate Chemokine Receptors on T Lymphocytes and Immature Dendritic Cells

    Authors: , , , , , , , , , , , , , - The Journal of Experimental Medicine 2002 cited by 276

  21. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis

    Authors: , , , , , , , , , , , , - Arthritis & Rheumatism 2008 cited by 138

  22. Autoantibodies targeting telomere-associated proteins in systemic sclerosis

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2021 cited by 43

  23. Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction

    Authors: , , , , , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 345

  24. Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Authors: , , , , , , - PLoS ONE 2014 cited by 75